Washington · 2025-2026
SB 5594
Concerning biosimilar medicines.
Bill record: Open States bulk CSV (bills/votes) ocd-bill/0c5d6fbe-289f-45be-ae4b-2adca0957570 CC0-1.0
Issue tags AI-classified
Classified by a local model from the bill's text; confidence shown. GovTally LLM enrichment (local oMLX)
Sponsors + 3 cosponsors
- Paul Harris Republican lead
- Annette Cleveland Democratic
- Bob Hasegawa Democratic
- Sharon Shewmake Democratic
Roll-call votes on this bill
| Motion / question | Chamber | Stage | Roll | Outcome | Yea | Nay | Other | Date | Source |
|---|---|---|---|---|---|---|---|---|---|
| 3rd Reading & Final Passage (#11) | upper | — | 5692d8af-b97b-46dc-b76f-eac76c405cbb | pass | 48 | 0 | 0 | Jan 21, 2026 | Open States bulk CSV (bills/votes) ocd-vote/5692d8af-b97b-46dc-b76f-eac76c405cbb CC0-1.0 |
| 3rd Reading & Final Passage (#7) | upper | — | 553af50e-d2cf-465a-97fb-130ec60b242e | pass | 48 | 0 | 0 | Mar 11, 2025 | Open States bulk CSV (bills/votes) ocd-vote/553af50e-d2cf-465a-97fb-130ec60b242e CC0-1.0 |